SC
RYTM icon

Sierra Capital’s Rhythm Pharmaceuticals RYTM Stock Holding History

Sierra Capital’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,400
Closed -$70K – 484
2022
Q4 		$70K Hold
2,400
– – 0.01% 237
2022
Q3 		$59K Hold
2,400
– – 0.01% 254
2022
Q2 		$10K Hold
2,400
– – ﹤0.01% 440
2022
Q1 		$28K Hold
2,400
– – ﹤0.01% 392
2021
Q4 		$24K Sell
2,400
-1,200
-33% -$13.5K ﹤0.01% 396
2021
Q3 		$47K Hold
3,600
– – 0.01% 309
2021
Q2 		$70K Hold
3,600
– – 0.01% 272
2021
Q1 		$77K Buy
+3,600
New +$104K 0.01% 259

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Sierra Capital's RYTM Position: Q1 2023 in Review

Sierra Capital sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2023, closing a stake of 2,400 shares — an estimated $70K sold.

Sierra Capital first reported a position in RYTM in Q1 2021 and held it in 8 quarters. The position peaked at $77K in Q1 2021. 126 funds tracked by Wall St. Rank hold RYTM as of Q1 2023.

  • Sierra Capital reported no remaining Rhythm Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Sierra Capital sold 2,400 Rhythm Pharmaceuticals shares in Q1 2023, an estimated $70K.
  • Sierra Capital first reported a position in Rhythm Pharmaceuticals in Q1 2021 and held it in 8 quarters.
  • Sierra Capital's Rhythm Pharmaceuticals position peaked at $77K in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2023.

Based on Sierra Capital's 13F filing for Q1 2023, filed 1 May 2023.